Showing results (11-20 of 243) with videos related to
Sort By:
Pageof 25
Clinical and Experimental Medicine|December 20, 2005
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune diseaseM Prete, F Perosa, E Favoino, et al.Journal of Immunological Methods|April 25, 1997
The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinantF Perosa, G Luccarelli, M Neri, et al.Clinical and Experimental Medicine|November 9, 2001
Human CD4 internal antigen anti-idiotypic monoclonal antibody. immunochemical and sequence analysisF Perosa, G Luccarelli, M Prete, et al.European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|October 3, 2002
Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expressionF Perosa, M Prete, G Luccarelli, et al.Leukemia|September 27, 2003
Vascular endothelial growth factor and its receptors in multiple myelomaR Ria, A M Roccaro, F Merchionne, et al.British Journal of Haematology|October 16, 1999
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myelomaF Perosa, G Luccarelli, M Prete, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
Human CD4-internal antigen anti-idiotypic monoclonal antibody: induction of a CD4-specific response in humansF Perosa, M Scudeletti, M A Imro, et al.Developmental Immunology|November 30, 2000
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progressionA Vacca, D Ribatti, R Ria, et al.Human Immunology|December 22, 1999
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotypeF Perosa, M Prete, G Luccarelli, et al.Experimental Hematology|August 10, 2001
alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cellsA Vacca, R Ria, M Presta, et al.Pageof 25